Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1130620090050010029
Journal of Clinical Neurology
2009 Volume.5 No. 1 p.29 ~ p.32
The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson¡¯s Disease and Multiple System Atrophy
Cho Jin-Whan

Kim Sung-Yeon
Park Sung-Sup
Jeon Beom S.
Abstract
Background and Purpose:The LRRK2 (PARK8; OMIM607060) substitution was recently identified as a causative mutation for Parkinson¡¯s disease (PD). The pathologic heterogeneity of LRRK2-positive patients suggests that mutation of the LRRK2 gene is associated with the pathogenesis of PD and Parkinson-plus disorders, such as multiple system atrophy (MSA). We previously reported that the G2019S LRRK2 mutation-which is the most common LRRK2 mutation- was not found in a sample of 453 Korean PD patients. In the present study, we extended the screening for the G2019S mutation to a larger group of PD and MSA patients.

Methods:We performed a genetic analysis of the G2019S mutation in 877 patients with PD and 199 patients with MSA using a standard PCR and restriction digestion method.

Results:None of the subjects carried the G2019S mutation.

Conclusions:The results of the present study support that the G2019S mutation is extremely rare in PD and is unlikely to be associated with MSA in the Korean population.
KEYWORD
Parkinson¡¯s disease, multiple system atrophy, LRRK2, G2019S mutation.
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø